PDF
(Download)
|
- Montmorency Tart Cherry (Prunus cerasus, Rosaceae)
- Cerebral Blood Flow
- Cognitive Function
|
Date:
08-31-2017 | HC# 021771-575
|
Re: Single Serving of Montmorency Tart Cherry Concentrate Improves Cerebral Blood Flow, but Not Cognitive Function
Keane
KM, Haskell-Ramsay CF, Veasey RC, Howatson G. Montmorency tart cherries (Prunus cerasus L.) modulate vascular
function acutely, in the absence of improvement in cognitive performance. Br J Nutr. December 2016;116(11):1935-1944.
Cognitive
decline during normal aging is related to a reduction in blood flow and oxygen
metabolism in the brain. Polyphenol-rich foods such as fruits have been studied
for their role in promoting cognitive function and preventing cardiovascular
and Alzheimer's diseases. In animal studies, feeding of Montmorency tart cherry
(Prunus cerasus, Rosaceae) extracts
have led to increased nitric oxide production and antioxidant status, and a
decrease in lipid oxidation and inflammatory markers, all related to healthy
brain function.
A
randomized, double-blinded, placebo-controlled, single-dose, crossover trial in
30 subjects (10 females and 20 males; aged 45-60 years) was performed at the
Department of Sport, Exercise and Rehabilitation at Northumbria University; Newcastle
upon Tyne, United Kingdom. The test material was a concentrate from Montmorency
tart cherry fruit. Exclusion criteria included those who had a neurological
disorder, head injury, or relevant food allergies, or who used tobacco (Nicotiana tabacum, Solanaceae) or
excessive caffeine, based on a self-reported assessment.
Subjects
were to follow a low-phenolic diet for 48 hours prior to each arm of the trial,
fast overnight (≥10 h), and abstain from strenuous exercise. Subjects received
either a 60-mL serving of a Montmorency tart cherry concentrate (MC as CherryActive®;
CherryActive Ltd; Sunbury, United Kingdom) diluted with 100 mL of water or a
placebo (fruit-flavored cordial [Kia-Ora®; Coca-Cola Enterprises; Uxbridge,
United Kingdom]) containing < 1% fruit. The treatment and placebo were
matched closely in macronutrients, color, and volume. MC contained ~68 mg/L
cyanidin-3-glucoside, ~161 mg/L polyphenols by gallic acid equivalents, and ~0.59
mg/L mean Trolox equivalents, a measure of antioxidant capacity.
On
study days, subjects reported to the lab from 7-9 a.m. and had blood pressure
taken. All subjects then had the following tests: (1) Baseline cognitive
assessment using the Computerised Mental Performance Assessment System (COMPASS;
Northumbria University); (2) Cerebral blood flow, including oxygenated and total
hemoglobin, using near-infrared spectroscopy (NIRS; NIRO-200NX; Hamamatsu
Photonics K.K.; Hamamatsu, Shizuoka, Japan); and (3) cerebral blood flow
velocity in the middle cerebral artery using Transcranial Doppler sonography (TCD;
Doppler-Box™; Compumedics DWL; Singen, Germany). The cognitive tasks included
digit vigilance, rapid visual information processing, the Stroop test (a
measure of attention, inhibition, and cognitive flexibility), and visual analog
scales. Subjects then consumed MC or placebo. Cognitive assessments and blood
flow measures were taken 1, 2, 3, and 5 h postconsumption; blood pressure was taken
hourly. Subjects watched a non-arousing DVD in between measurements. After a
washout period of at least 14 days, subjects returned for the opposite arm of
the study.
Twenty-seven
subjects completed the study, and baseline measurements between treatment and
placebo groups were similar. All subjects complied with the low-polyphenolic
diet, according to the food diaries. No adverse events were reported. No
measures of mood or cognitive function were affected; however, concentrations
of total and oxyhemoglobin were significantly improved during the task period 1
h post-MC consumption (P = 0.019). MC consumption significantly lowered
systolic blood pressure (P ≤ 0.05) over a period of 3 h, with a maximum
reduction of 6 ± 2 mmHg at 1 h after consumption.
The
authors suggest that a single serving of MC can modulate markers of vascular
function that may not translate to measurable differences in cognition or mood.
Limitations of the study include the acute dosing design, which may not have permitted
enough time to realize the potential impact of the treatment. The study
excluded subjects consuming a polyphenol-rich diet, which may not reflect
real-world applications. Also, practice and fatigue effects for acute cognitive-function
studies can be difficult to predict and control.
Overall,
the study showed that a single serving of MC can improve some measures of
cerebral blood flow, based on increased concentrations of total and
oxyhemoglobin using NIRS. The authors also remarked that the reduction in
systolic blood pressure was consistent with previous studies on concentrates
from this particular type of cherry.
The
Cherry Research Committee of the Cherry Marketing Institute (DeWitt, Michigan)
provided support for a PhD studentship associated with the study. All other
study funding was provided by Northumbria University. The funders had no role
in the design of the study, data collection and analysis, decision to publish,
or preparation of the study manuscript.
—Blake Ebersole
|